Details of the Drug Formulations

General Information of Drug (ID: DMICDLV)

• Drug Name: Lorlatinib Drug Info
• Synonyms: Loratinib; UNII-OSP71S83EU; Lorlatinib,PF-06463922; OSP71S83EU; lorlantinib; 4clj; 4cli; Lorlatinib [USAN:INN]; Lorlatinib (JAN/USAN/INN); PF06463922(Lorlatinib); GTPL7476; SCHEMBL15261807; EX-A828; MolPort-035-789-724; KS-00000T6C; 2641AH; ZINC98208524; s7536; MFCD28144520; BDBM50018830; AKOS027250753; DB12130; CS-39

Indication

Disease Entry	ICD 11	Status	REF
Non-small-cell lung cancer	2C25.Y	Approved	[1]

• Cross-matching ID:
  PubChem CID: 71731823
  ChEBI ID: CHEBI:143117
  CAS Number: 1454846-35-5
  TTD ID: D0AF6O
  INTEDE ID: DR0980
  ACDINA ID: D01222

Full List of Drug Formulations Containing This Drug

Lorlatinib 100 mg tablet

Company	Formulation ID	FDA Description
Pfizer Laboratories Div Pfizer	F24310	Microcrystalline Cellulose; Dibasic Calcium Phosphate Anhydrous; Sodium Starch Glycolate; Magnesium Stearate; Hydroxypropyl Methylcellulose (Hpmc) 2910/Hypromellose; Lactose Monohydrate; Macrogol/Polyethylene Glycol (Peg) 3350; Triacetin; Titanium Dioxide; Ferrosoferric Oxide/Black Iron Oxide; Iron Oxide Red

Lorlatinib 25 mg tablet

Company	Formulation ID	FDA Description
Pfizer Laboratories Div Pfizer	F24370	Microcrystalline Cellulose; Dibasic Calcium Phosphate Anhydrous; Sodium Starch Glycolate; Magnesium Stearate; Hydroxypropyl Methylcellulose (Hpmc) 2910/Hypromellose; Lactose Monohydrate; Macrogol/Polyethylene Glycol (Peg) 3350; Triacetin; Titanium Dioxide; Ferrosoferric Oxide/Black Iron Oxide; Iron Oxide Red

References

• [1] 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.